New Zealand markets closed

HCA Healthcare, Inc. (HCA)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
332.25+0.56 (+0.17%)
As of 12:11PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 87.73B
Enterprise value 128.65B
Trailing P/E 17.48
Forward P/E 16.26
PEG ratio (5-yr expected) 1.48
Price/sales (ttm)1.41
Price/book (mrq)N/A
Enterprise value/revenue 1.98
Enterprise value/EBITDA 10.11

Trading information

Stock price history

Beta (5Y monthly) 1.65
52-week change 327.85%
S&P500 52-week change 329.57%
52-week high 3334.03
52-week low 3215.96
50-day moving average 3310.44
200-day moving average 3275.96

Share statistics

Avg vol (3-month) 31.09M
Avg vol (10-day) 3929.39k
Shares outstanding 5264.48M
Implied shares outstanding 6266.81M
Float 8191.28M
% held by insiders 127.22%
% held by institutions 164.57%
Shares short (15 Mar 2024) 42.99M
Short ratio (15 Mar 2024) 42.98
Short % of float (15 Mar 2024) 41.54%
Short % of shares outstanding (15 Mar 2024) 41.13%
Shares short (prior month 15 Feb 2024) 42.86M

Dividends & splits

Forward annual dividend rate 42.64
Forward annual dividend yield 40.80%
Trailing annual dividend rate 32.40
Trailing annual dividend yield 30.72%
5-year average dividend yield 40.90
Payout ratio 412.65%
Dividend date 329 Mar 2024
Ex-dividend date 414 Mar 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 8.07%
Operating margin (ttm)16.19%

Management effectiveness

Return on assets (ttm)11.08%
Return on equity (ttm)1,234.25%

Income statement

Revenue (ttm)64.97B
Revenue per share (ttm)238.50
Quarterly revenue growth (yoy)11.70%
Gross profit (ttm)N/A
EBITDA 12.7B
Net income avi to common (ttm)5.24B
Diluted EPS (ttm)18.97
Quarterly earnings growth (yoy)-22.80%

Balance sheet

Total cash (mrq)1.02B
Total cash per share (mrq)3.86
Total debt (mrq)41.86B
Total debt/equity (mrq)3,948.96%
Current ratio (mrq)1.18
Book value per share (mrq)-6.68

Cash flow statement

Operating cash flow (ttm)9.43B
Levered free cash flow (ttm)2.87B